COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
C20orf181 |
|
chromosome 20 open reading frame 181
|
|
|
0.479 |
0.885 |
LINC02605 |
|
long intergenic non-protein coding RNA 2605
|
|
|
0.490 |
0.769 |
PERCC1 |
A0A1W2PR82
|
proline and glutamate rich with coiled coil 1
|
|
|
0.552 |
0.808 |
CTAA1 |
|
cataract, anterior polar 1
|
|
|
0.568 |
0.731 |
LOH19CR1 |
|
loss of heterozygosity, 19, chromosomal region 1
|
|
|
0.569 |
0.808 |
DEFB103B |
P81534
|
defensin beta 103B
|
|
|
0.572 |
0.731 |
DEFB103A |
P81534
|
defensin beta 103A
|
|
|
0.573 |
0.731 |
MFT2 |
|
Trichoepithelioma, multiple familial, 2
|
|
|
0.601 |
0.692 |
RNR1 |
A0A0C5B5G6
|
s-rRNA
|
|
|
0.626 |
0.769 |
DIP |
|
interstitial pneumonitis, desquamative, familial
|
|
|
0.678 |
0.462 |
PTPRVP |
|
protein tyrosine phosphatase receptor type V, pseudogene
|
|
|
0.705 |
0.577 |
ST11 |
|
suppression of tumorigenicity 11 (pancreas)
|
|
|
0.722 |
0.346 |
VIM2P |
|
vimentin 2, pseudogene
|
|
|
0.760 |
0.385 |
SPPL2B |
Q8TCT7
|
signal peptide peptidase like 2B
|
Enzyme
|
|
0.861 |
0.192 |
IS5 |
|
scoliosis, idiopathic, susceptibility to, 5
|
|
|
1.000 |
0.077 |
ABCC2 |
Q92887
|
ATP binding cassette subfamily C member 2
|
Transporter
|
5.2E-47 |
0.483 |
0.808 |
TRPA1 |
O75762
|
transient receptor potential cation channel subfamily A member 1
|
Ion channel
|
7.2E-35 |
0.546 |
0.846 |
ABCG2 |
Q9UNQ0
|
ATP binding cassette subfamily G member 2 (Junior blood group)
|
Transporter
|
2.1E-32 |
0.419 |
0.885 |
NOD2 |
Q9HC29
|
nucleotide binding oligomerization domain containing 2
|
Enzyme
|
2.0E-30 |
0.423 |
0.923 |
VWF |
P04275
|
von Willebrand factor
|
Enzyme modulator
|
3.2E-25 |
0.408 |
0.885 |